Vyepti is currently authorized in the United States and the EU for the therapy of migraine headache.
发布者：BY MARKETWIRE，转转请注明出处：https://robotalks.cn/lundbeck-closer-to-launching-vyepti-in-asia-after-phase-3-success/
Lundbeck closer to launching Vyepti in Asia after Phase 3 success
赞 (0)
关于作者
Boehringer Ingelheim stops development of Gubra obesity drug
上一篇
3 11 月, 2024 2:20 下午
Novo Nordisk’s semaglutide shown to reduce pain from knee osteoarthritis
下一篇
3 11 月, 2024 2:20 下午
相关推荐
-
BMW Motorrad presents the BMW R 12 S.
With the BMW R 12 S, BMW Motorrad is increasing its Heritage array with a suitable homage to the legendary R 90 S, which in 1973 not just establish a flashy exclamation mark for BM…
-
3 Questions: Evidence for planetary formation through gravitational instability
Exoplanets create in protoplanetary disks, a collection of area dirt and gas orbiting a celebrity. The leading concept of worldly development, called core accession, happens when g…
-
“Airbus Pauses Plan to Bring NextGen eVTOL Aircraft to Market”
Jet shocked the aeronautics sector today, after an instruction to reporters specifying the firm has actually pushed the time out switch on bringing its NextGen eVTOL to market. The…
